Icon Close

Seagen is now part of Pfizer!  Please visit Pfizer.com for more information.

For US residents only.

Who We Are

Corporate Responsibility at Seagen

David Epstein
David EpsteinCEO, Seagen
Download Corporate Responsibility Report

As we commemorate our 25th year of delivering transformative cancer therapies, I am honored to present our annual Corporate Responsibility Report, a testament to Seagen's enduring commitment to responsible and sustainable practices. This milestone year fills us with immense pride, reflecting not only on our journey of innovation and growth but our unwavering dedication to linking scientific breakthroughs to lives.

I invite you to read about our efforts as we continue to push the boundaries of innovation while upholding our commitment to environmental sustainability, social responsibility, and strong governance. Together, we are creating a future where we can offer patients hope, communities can thrive, and our business continues to grow with purpose and care.

CORPORATE RESPONSIBILITY BY THE NUMBERS

Diversity, Equity, and Inclusion[1]

57%

of our global workforce identify as women

41%

of our global leadership (at the executive director level and above) identify as women

36%

of our U.S workforce are racially or ethnically diverse

32%

of our U.S. leadership (at the executive director level and above) are racially or ethnically diverse

Human Capital

77%

positive responses were received from our employee engagement survey, exceeding the industry average for Life Sciences by 8%

~200

professional and career development classes are offered[4]

16%

of open roles were filled with internal hires[4]

Patient Access and Community Outreach

110+

virtual patient advocacy conferences and webinars sponsored to help people with cancer and caregivers connect with the information they need[4]
Innovation For Sustainable Future
Gloria SinglaResearch Associate III,Pharmaceutical Sciences, Seagen

Innovation for a Sustainable Future

For 25 years, Seagen has advanced the development of targeted cancer therapeutics with ADC technology at our core, a drug class we have pioneered since 1998. Our rich history of innovation, deep scientific expertise in ADCs, R&D capabilities, and entrepreneurial spirit enable Seagen to push further and dig deeper to accelerate breakthrough therapies that meaningfully improve the lives of people with cancer.

147K+

total patients treated with Seagen medications worldwide to date[3]
Learn More
Patient and Community Care
Josh RaubSenior Medical Science Liaison, Seagenand Former ECHELON-1 Patient

Patient and Community Care

Cancer persists and, at Seagen, we stand by our duty to do more for patients. By maintaining meaningful connections and working collaboratively with patients and their advocates, we can ensure that the needs of our patients are the focus of our objectives and products.

$4.6M

invested in national patient advocacy support and activities across our priority areas of research in the U.S. in 2022
Learn More
Employee Empowerment
Paul WaltersSenior Manager,IT Help Desk, Seagen

Employee Empowerment

We are driven by our people who, inspired by our science, embrace complexity and dig deeper to extend and improve the lives of people with cancer. Our employees and their dedication to our impactful work serve as the catalyst for our legacy of innovation. We are committed to ensuring that our employees feel engaged at work and that we support their career growth to retain our world-class talent

90%

of employees feel proud to work for Seagen and would recommend Seagen as a good place to work
Learn More
Responsible Stewardship
Alicia LazoreEHS Specialist II,Environmental, Health, Safety, and Sustainability, Seagen

Responsible Stewardship

We recognize the interconnectedness between protecting our patients, communities, and employees with our responsibility to safeguard the environment. We are committed to managing and minimizing our environmental footprint to create a better, more sustainable future for all.

86%

of the energy mix at our Bothell, Washington headquarters came from renewable energy sources[2]
Learn More
Doug
Doug MaffeiVice President,Investor Relations and ESG, Seagen

The Importance of ESG to our Patients and Business

Our purpose at Seagen is to work together with urgency to improve and extend the lives of people living with cancer via transformative therapies. Science and patients drive us, and core to our approach is how we operate and positively impact people and our communities.

Integrating ESG into our operations is an important strategic business approach. It enables us to maintain our innovative and growth-focused culture, while adapting to external environmental changes. ESG provides a competitive advantage that helps to generate long-term value for Seagen and its stakeholders by increasing risk management and creating innovative solutions for socioeconomic and environmental issues.

Corporate Responsibility Report
Corporate Responsibility Report

Download Seagen’s 2022/2023 Corporate Responsibility Report: Linking Breakthroughs to Lives

Download Full Report
[1] As of December 31, 2022.
[2] Reflects the 2022 energy mix of our utility supplier
where our headquarters and campus are located, based
on the provider's 2021 disclosure.
[3] Estimates as of June 30, 2023.
[4] For the period January 1, 2022 to December 31, 2022.
corp_gov
Corporate Governance GuidelinesRead more
code_business
Code of Business Conduct and EthicsRead more
supplier
Supplier Code of ConductRead more
Human Rights
Human Rights Policy StatementRead more